Skip to content

Ondas, Inc. ONDS R&D capitalization

R&D capitalization at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
$752K
Parker-Hannifin logo
Parker-HannifinPH
$172M+17.8%
Curtiss-Wright logo
Curtiss-WrightCW
$52.53M-13.6%
Corvex
 logo
Corvex MOVE
$5.16M-27.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$233.49M-27.8%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$6.06M-47.2%

Other financials

Income statement

See full
Revenue$50.1M+1,080%
Gross profit$24.7M+1,557%
Operating income-$42.7M-314%
Net income$362.8M+2,666%
EPS (diluted)$0.56+473%

Balance sheet

See full
Cash & equivalents$1.0B+3,989%
Total debt$12.5M-64.8%
Total equity$1.1B+4,018%
Total assets$2.4B+2,232%

Cash flow

See full
Operating cash flow-$51.3M-670%
CapEx$1.3M+679%
Free cash flow-$52.6M-671%

Valuation

See full
Market cap$4.82B+3,648%

Profitability

See full
Gross margin44.8%+24.2pp
Operating margin-93.9%-39.2pp
Net margin253.3%+158pp
FCF margin-89.6%-37.2pp

Returns & leverage

See full
Return on equity44.5%+25.0pp
Debt / equity-1.4×
Current ratio10.9×+10.1×

Where this comes from

Reported directly by Ondas, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts.

The official record: Ondas, Inc. ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ondas, Inc. 's r&d capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ondas, Inc. 's r&d capitalization?
Ondas, Inc. (ONDS) reported r&d capitalization of $752K in Q4 2025.
What is the long-term trend for Ondas, Inc. 's r&d capitalization?
Over 2 years (2023 to 2025), Ondas, Inc. 's r&d capitalization has grown at a 0.0% compound annual growth rate (CAGR), from $752K to $752K.
What does r&d capitalization mean?
This metric represents the portion of research and development expenditures that have been capitalized as intangible assets rather than expensed immediately in the period incurred. By deferring these costs, the company aligns the recognition of expenses with the future economic benefits expected from the developed technology. This accounting treatment provides insight into the company's long-term investment strategy in proprietary software and hardware innovation.